nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—Differentiation Pathway—ALK—lymphatic system cancer	0.07	0.287	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Mecp2 and Associated Rett Syndrome—BCL6—lymphatic system cancer	0.053	0.217	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Differentiation Pathway—ALK—lymphatic system cancer	0.0444	0.182	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Differentiation Pathway—ALK—lymphatic system cancer	0.0405	0.166	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Mecp2 and Associated Rett Syndrome—BCL6—lymphatic system cancer	0.0307	0.126	CbGpPWpGaD
Pentosan Polysulfate—Angina pectoris—Fludarabine—lymphatic system cancer	0.00558	0.00738	CcSEcCtD
Pentosan Polysulfate—Sweating—Teniposide—lymphatic system cancer	0.00557	0.00737	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00551	0.00729	CcSEcCtD
Pentosan Polysulfate—Appetite absent—Methotrexate—lymphatic system cancer	0.00544	0.00719	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Vincristine—lymphatic system cancer	0.00504	0.00667	CcSEcCtD
Pentosan Polysulfate—Infection—Mechlorethamine—lymphatic system cancer	0.00499	0.0066	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Fludarabine—lymphatic system cancer	0.00498	0.00658	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00492	0.00651	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Mitoxantrone—lymphatic system cancer	0.00491	0.0065	CcSEcCtD
Pentosan Polysulfate—Haematuria—Fludarabine—lymphatic system cancer	0.00487	0.00644	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Fludarabine—lymphatic system cancer	0.00481	0.00637	CcSEcCtD
Pentosan Polysulfate—Anorexia—Mechlorethamine—lymphatic system cancer	0.00479	0.00634	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Fludarabine—lymphatic system cancer	0.00479	0.00634	CcSEcCtD
Pentosan Polysulfate—Alopecia—Teniposide—lymphatic system cancer	0.00461	0.0061	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Fludarabine—lymphatic system cancer	0.00455	0.00602	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00437	0.00578	CcSEcCtD
Pentosan Polysulfate—Anaemia—Teniposide—lymphatic system cancer	0.0042	0.00555	CcSEcCtD
Pentosan Polysulfate—Agitation—Teniposide—lymphatic system cancer	0.00417	0.00552	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Teniposide—lymphatic system cancer	0.00406	0.00538	CcSEcCtD
Pentosan Polysulfate—Alopecia—Fludarabine—lymphatic system cancer	0.00405	0.00536	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00391	0.00518	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Bleomycin—lymphatic system cancer	0.0038	0.00502	CcSEcCtD
Pentosan Polysulfate—Dehydration—Vincristine—lymphatic system cancer	0.00376	0.00498	CcSEcCtD
Pentosan Polysulfate—Oedema—Teniposide—lymphatic system cancer	0.0037	0.0049	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0037	0.0049	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.0037	0.0049	CcSEcCtD
Pentosan Polysulfate—Anaemia—Fludarabine—lymphatic system cancer	0.00369	0.00488	CcSEcCtD
Pentosan Polysulfate—Infection—Teniposide—lymphatic system cancer	0.00368	0.00487	CcSEcCtD
Pentosan Polysulfate—Agitation—Fludarabine—lymphatic system cancer	0.00367	0.00485	CcSEcCtD
Pentosan Polysulfate—Dehydration—Mitoxantrone—lymphatic system cancer	0.00367	0.00485	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Bleomycin—lymphatic system cancer	0.00365	0.00483	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00363	0.0048	CcSEcCtD
Pentosan Polysulfate—Malaise—Fludarabine—lymphatic system cancer	0.0036	0.00476	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00358	0.00474	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Fludarabine—lymphatic system cancer	0.00357	0.00472	CcSEcCtD
Pentosan Polysulfate—Haematuria—Bleomycin—lymphatic system cancer	0.00357	0.00472	CcSEcCtD
Pentosan Polysulfate—Pruritus—Mechlorethamine—lymphatic system cancer	0.00356	0.0047	CcSEcCtD
Pentosan Polysulfate—Anorexia—Teniposide—lymphatic system cancer	0.00353	0.00467	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00344	0.00455	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Fludarabine—lymphatic system cancer	0.0034	0.00449	CcSEcCtD
Pentosan Polysulfate—Myalgia—Fludarabine—lymphatic system cancer	0.0034	0.00449	CcSEcCtD
Pentosan Polysulfate—Discomfort—Fludarabine—lymphatic system cancer	0.00336	0.00444	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00332	0.00439	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Teniposide—lymphatic system cancer	0.0033	0.00437	CcSEcCtD
Pentosan Polysulfate—Depression—Carmustine—lymphatic system cancer	0.00326	0.00431	CcSEcCtD
Pentosan Polysulfate—Oedema—Fludarabine—lymphatic system cancer	0.00326	0.00431	CcSEcCtD
Pentosan Polysulfate—Infection—Fludarabine—lymphatic system cancer	0.00323	0.00428	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Teniposide—lymphatic system cancer	0.00322	0.00426	CcSEcCtD
Pentosan Polysulfate—Vomiting—Mechlorethamine—lymphatic system cancer	0.00319	0.00423	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00319	0.00422	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00319	0.00422	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Carmustine—lymphatic system cancer	0.00318	0.00421	CcSEcCtD
Pentosan Polysulfate—Rash—Mechlorethamine—lymphatic system cancer	0.00317	0.00419	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00317	0.00419	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Vincristine—lymphatic system cancer	0.00316	0.00419	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00315	0.00416	CcSEcCtD
Pentosan Polysulfate—Depression—Vincristine—lymphatic system cancer	0.00311	0.00411	CcSEcCtD
Pentosan Polysulfate—Anorexia—Fludarabine—lymphatic system cancer	0.0031	0.00411	CcSEcCtD
Pentosan Polysulfate—Weight increased—Mitoxantrone—lymphatic system cancer	0.0031	0.0041	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00308	0.00408	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Teniposide—lymphatic system cancer	0.00305	0.00404	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Vincristine—lymphatic system cancer	0.00304	0.00402	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00303	0.00401	CcSEcCtD
Pentosan Polysulfate—Sweating—Vincristine—lymphatic system cancer	0.00299	0.00396	CcSEcCtD
Pentosan Polysulfate—Nausea—Mechlorethamine—lymphatic system cancer	0.00298	0.00395	CcSEcCtD
Pentosan Polysulfate—Alopecia—Bleomycin—lymphatic system cancer	0.00297	0.00393	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00297	0.00392	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00296	0.00392	CcSEcCtD
Pentosan Polysulfate—Jaundice—Mitoxantrone—lymphatic system cancer	0.00296	0.00392	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00295	0.00391	CcSEcCtD
Pentosan Polysulfate—Urticaria—Teniposide—lymphatic system cancer	0.00294	0.00389	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Teniposide—lymphatic system cancer	0.00293	0.00387	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Fludarabine—lymphatic system cancer	0.00292	0.00387	CcSEcCtD
Pentosan Polysulfate—Sweating—Mitoxantrone—lymphatic system cancer	0.00291	0.00385	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Fludarabine—lymphatic system cancer	0.0029	0.00384	CcSEcCtD
Pentosan Polysulfate—Haematuria—Mitoxantrone—lymphatic system cancer	0.0029	0.00383	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Fludarabine—lymphatic system cancer	0.00287	0.00379	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00285	0.00377	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Fludarabine—lymphatic system cancer	0.00283	0.00374	CcSEcCtD
Pentosan Polysulfate—Constipation—Fludarabine—lymphatic system cancer	0.00278	0.00368	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00273	0.00362	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Teniposide—lymphatic system cancer	0.00273	0.00361	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00271	0.00359	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00271	0.00358	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00271	0.00358	CcSEcCtD
Pentosan Polysulfate—Anaemia—Bleomycin—lymphatic system cancer	0.0027	0.00358	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00268	0.00355	CcSEcCtD
Pentosan Polysulfate—Malaise—Bleomycin—lymphatic system cancer	0.00264	0.00349	CcSEcCtD
Pentosan Polysulfate—Pruritus—Teniposide—lymphatic system cancer	0.00262	0.00347	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Bleomycin—lymphatic system cancer	0.00262	0.00346	CcSEcCtD
Pentosan Polysulfate—Alopecia—Carmustine—lymphatic system cancer	0.00259	0.00343	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Methotrexate—lymphatic system cancer	0.00255	0.00338	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Teniposide—lymphatic system cancer	0.00253	0.00335	CcSEcCtD
Pentosan Polysulfate—Myalgia—Bleomycin—lymphatic system cancer	0.00249	0.00329	CcSEcCtD
Pentosan Polysulfate—Alopecia—Vincristine—lymphatic system cancer	0.00247	0.00327	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—NPM1—lymphatic system cancer	0.00247	0.0101	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Bleomycin—lymphatic system cancer	0.00246	0.00326	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00245	0.00324	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Methotrexate—lymphatic system cancer	0.00245	0.00324	CcSEcCtD
Pentosan Polysulfate—Alopecia—Mitoxantrone—lymphatic system cancer	0.00241	0.00319	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0024	0.00317	CcSEcCtD
Pentosan Polysulfate—Oedema—Bleomycin—lymphatic system cancer	0.00239	0.00316	CcSEcCtD
Pentosan Polysulfate—Infection—Bleomycin—lymphatic system cancer	0.00237	0.00314	CcSEcCtD
Pentosan Polysulfate—Anaemia—Carmustine—lymphatic system cancer	0.00236	0.00312	CcSEcCtD
Pentosan Polysulfate—Vomiting—Teniposide—lymphatic system cancer	0.00236	0.00312	CcSEcCtD
Pentosan Polysulfate—Agitation—Carmustine—lymphatic system cancer	0.00235	0.0031	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00234	0.00309	CcSEcCtD
Pentosan Polysulfate—Rash—Teniposide—lymphatic system cancer	0.00234	0.00309	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Teniposide—lymphatic system cancer	0.00233	0.00309	CcSEcCtD
Pentosan Polysulfate—Headache—Teniposide—lymphatic system cancer	0.00232	0.00307	CcSEcCtD
Pentosan Polysulfate—Pruritus—Fludarabine—lymphatic system cancer	0.0023	0.00305	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Carmustine—lymphatic system cancer	0.00229	0.00302	CcSEcCtD
Pentosan Polysulfate—Anorexia—Bleomycin—lymphatic system cancer	0.00228	0.00301	CcSEcCtD
Pentosan Polysulfate—Anaemia—Vincristine—lymphatic system cancer	0.00225	0.00298	CcSEcCtD
Pentosan Polysulfate—Agitation—Vincristine—lymphatic system cancer	0.00224	0.00296	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Methotrexate—lymphatic system cancer	0.00224	0.00296	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Fludarabine—lymphatic system cancer	0.00223	0.00295	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.0022	0.00291	CcSEcCtD
Pentosan Polysulfate—Nausea—Teniposide—lymphatic system cancer	0.0022	0.00291	CcSEcCtD
Pentosan Polysulfate—Anaemia—Mitoxantrone—lymphatic system cancer	0.00219	0.0029	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Vincristine—lymphatic system cancer	0.00218	0.00289	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00217	0.00288	CcSEcCtD
Pentosan Polysulfate—Myalgia—Carmustine—lymphatic system cancer	0.00217	0.00288	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Bleomycin—lymphatic system cancer	0.00214	0.00284	CcSEcCtD
Pentosan Polysulfate—Malaise—Mitoxantrone—lymphatic system cancer	0.00214	0.00283	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Bleomycin—lymphatic system cancer	0.00213	0.00282	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00212	0.00281	CcSEcCtD
Pentosan Polysulfate—Oedema—Carmustine—lymphatic system cancer	0.00208	0.00276	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Bleomycin—lymphatic system cancer	0.00208	0.00275	CcSEcCtD
Pentosan Polysulfate—Myalgia—Vincristine—lymphatic system cancer	0.00207	0.00275	CcSEcCtD
Pentosan Polysulfate—Infection—Carmustine—lymphatic system cancer	0.00207	0.00274	CcSEcCtD
Pentosan Polysulfate—Vomiting—Fludarabine—lymphatic system cancer	0.00207	0.00274	CcSEcCtD
Pentosan Polysulfate—Rash—Fludarabine—lymphatic system cancer	0.00205	0.00272	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Fludarabine—lymphatic system cancer	0.00205	0.00271	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00204	0.0027	CcSEcCtD
Pentosan Polysulfate—Headache—Fludarabine—lymphatic system cancer	0.00204	0.0027	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00202	0.00267	CcSEcCtD
Pentosan Polysulfate—Myalgia—Mitoxantrone—lymphatic system cancer	0.00202	0.00267	CcSEcCtD
Pentosan Polysulfate—Discomfort—Mitoxantrone—lymphatic system cancer	0.002	0.00264	CcSEcCtD
Pentosan Polysulfate—Oedema—Vincristine—lymphatic system cancer	0.00199	0.00263	CcSEcCtD
Pentosan Polysulfate—Anorexia—Carmustine—lymphatic system cancer	0.00199	0.00263	CcSEcCtD
Pentosan Polysulfate—Infection—Vincristine—lymphatic system cancer	0.00198	0.00261	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00197	0.0026	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00195	0.00258	CcSEcCtD
Pentosan Polysulfate—Oedema—Mitoxantrone—lymphatic system cancer	0.00194	0.00256	CcSEcCtD
Pentosan Polysulfate—Nausea—Fludarabine—lymphatic system cancer	0.00193	0.00256	CcSEcCtD
Pentosan Polysulfate—Infection—Mitoxantrone—lymphatic system cancer	0.00192	0.00255	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00192	0.00254	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.0019	0.00251	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.0019	0.00251	CcSEcCtD
Pentosan Polysulfate—Urticaria—Bleomycin—lymphatic system cancer	0.0019	0.00251	CcSEcCtD
Pentosan Polysulfate—Anorexia—Vincristine—lymphatic system cancer	0.0019	0.00251	CcSEcCtD
Pentosan Polysulfate—Insomnia—Carmustine—lymphatic system cancer	0.00188	0.00249	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00187	0.00248	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Carmustine—lymphatic system cancer	0.00187	0.00248	CcSEcCtD
Pentosan Polysulfate—Mood swings—Methotrexate—lymphatic system cancer	0.00186	0.00246	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Carmustine—lymphatic system cancer	0.00186	0.00246	CcSEcCtD
Pentosan Polysulfate—Anorexia—Mitoxantrone—lymphatic system cancer	0.00185	0.00244	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00181	0.0024	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00181	0.0024	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Carmustine—lymphatic system cancer	0.00181	0.0024	CcSEcCtD
Pentosan Polysulfate—Insomnia—Vincristine—lymphatic system cancer	0.0018	0.00238	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Vincristine—lymphatic system cancer	0.00179	0.00236	CcSEcCtD
Pentosan Polysulfate—Constipation—Carmustine—lymphatic system cancer	0.00178	0.00236	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00176	0.00234	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00176	0.00233	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00174	0.0023	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Vincristine—lymphatic system cancer	0.00173	0.00229	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00173	0.00229	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Carmustine—lymphatic system cancer	0.00172	0.00227	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00171	0.00226	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.0017	0.00225	CcSEcCtD
Pentosan Polysulfate—Constipation—Vincristine—lymphatic system cancer	0.0017	0.00225	CcSEcCtD
Pentosan Polysulfate—Pruritus—Bleomycin—lymphatic system cancer	0.00169	0.00223	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00168	0.00223	CcSEcCtD
Pentosan Polysulfate—Constipation—Mitoxantrone—lymphatic system cancer	0.00166	0.00219	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Carmustine—lymphatic system cancer	0.00165	0.00218	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00163	0.00215	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00163	0.00215	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.0016	0.00211	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00158	0.0021	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Vincristine—lymphatic system cancer	0.00157	0.00208	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—NPM1—lymphatic system cancer	0.00157	0.00642	CbGpPWpGaD
Pentosan Polysulfate—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00155	0.00205	CcSEcCtD
Pentosan Polysulfate—Urticaria—Mitoxantrone—lymphatic system cancer	0.00154	0.00204	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Carmustine—lymphatic system cancer	0.00154	0.00203	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00153	0.00203	CcSEcCtD
Pentosan Polysulfate—Vomiting—Bleomycin—lymphatic system cancer	0.00152	0.00201	CcSEcCtD
Pentosan Polysulfate—Depression—Methotrexate—lymphatic system cancer	0.00151	0.002	CcSEcCtD
Pentosan Polysulfate—Rash—Bleomycin—lymphatic system cancer	0.00151	0.00199	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Bleomycin—lymphatic system cancer	0.0015	0.00199	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Methotrexate—lymphatic system cancer	0.00148	0.00195	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00147	0.00195	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Vincristine—lymphatic system cancer	0.00147	0.00194	CcSEcCtD
Pentosan Polysulfate—Sweating—Methotrexate—lymphatic system cancer	0.00145	0.00192	CcSEcCtD
Pentosan Polysulfate—Haematuria—Methotrexate—lymphatic system cancer	0.00144	0.00191	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—NPM1—lymphatic system cancer	0.00143	0.00585	CbGpPWpGaD
Pentosan Polysulfate—Epistaxis—Methotrexate—lymphatic system cancer	0.00143	0.00189	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00143	0.00189	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Carmustine—lymphatic system cancer	0.00143	0.00189	CcSEcCtD
Pentosan Polysulfate—Nausea—Bleomycin—lymphatic system cancer	0.00142	0.00188	CcSEcCtD
Pentosan Polysulfate—Dizziness—Carmustine—lymphatic system cancer	0.00138	0.00182	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vincristine—lymphatic system cancer	0.00136	0.0018	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Methotrexate—lymphatic system cancer	0.00135	0.00178	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00133	0.00175	CcSEcCtD
Pentosan Polysulfate—Vomiting—Carmustine—lymphatic system cancer	0.00132	0.00175	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vincristine—lymphatic system cancer	0.00132	0.00174	CcSEcCtD
Pentosan Polysulfate—Rash—Carmustine—lymphatic system cancer	0.00131	0.00174	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Carmustine—lymphatic system cancer	0.00131	0.00174	CcSEcCtD
Pentosan Polysulfate—Headache—Carmustine—lymphatic system cancer	0.00131	0.00173	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Methotrexate—lymphatic system cancer	0.00127	0.00168	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vincristine—lymphatic system cancer	0.00126	0.00167	CcSEcCtD
Pentosan Polysulfate—Rash—Vincristine—lymphatic system cancer	0.00125	0.00166	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vincristine—lymphatic system cancer	0.00125	0.00166	CcSEcCtD
Pentosan Polysulfate—Headache—Vincristine—lymphatic system cancer	0.00125	0.00165	CcSEcCtD
Pentosan Polysulfate—Nausea—Carmustine—lymphatic system cancer	0.00124	0.00164	CcSEcCtD
Pentosan Polysulfate—Vomiting—Mitoxantrone—lymphatic system cancer	0.00123	0.00163	CcSEcCtD
Pentosan Polysulfate—Rash—Mitoxantrone—lymphatic system cancer	0.00122	0.00162	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00122	0.00161	CcSEcCtD
Pentosan Polysulfate—Headache—Mitoxantrone—lymphatic system cancer	0.00121	0.00161	CcSEcCtD
Pentosan Polysulfate—Alopecia—Methotrexate—lymphatic system cancer	0.0012	0.00159	CcSEcCtD
Pentosan Polysulfate—Nausea—Vincristine—lymphatic system cancer	0.00118	0.00156	CcSEcCtD
Pentosan Polysulfate—Nausea—Mitoxantrone—lymphatic system cancer	0.00115	0.00152	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.0011	0.00145	CcSEcCtD
Pentosan Polysulfate—Anaemia—Methotrexate—lymphatic system cancer	0.00109	0.00145	CcSEcCtD
Pentosan Polysulfate—Malaise—Methotrexate—lymphatic system cancer	0.00107	0.00141	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Methotrexate—lymphatic system cancer	0.00106	0.0014	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—lymphatic system cancer	0.00101	0.00133	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—lymphatic system cancer	0.00101	0.00133	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—lymphatic system cancer	0.000995	0.00132	CcSEcCtD
Pentosan Polysulfate—Infection—Methotrexate—lymphatic system cancer	0.000959	0.00127	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000945	0.00125	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000933	0.00123	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—lymphatic system cancer	0.00092	0.00122	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000879	0.00116	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—lymphatic system cancer	0.000873	0.00115	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methotrexate—lymphatic system cancer	0.000867	0.00115	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—lymphatic system cancer	0.00086	0.00114	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methotrexate—lymphatic system cancer	0.00085	0.00112	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Methotrexate—lymphatic system cancer	0.000839	0.00111	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000795	0.00105	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000789	0.00104	CcSEcCtD
Pentosan Polysulfate—Urticaria—Methotrexate—lymphatic system cancer	0.000767	0.00101	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methotrexate—lymphatic system cancer	0.000763	0.00101	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000711	0.000941	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—lymphatic system cancer	0.000683	0.000903	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Methotrexate—lymphatic system cancer	0.00066	0.000874	CcSEcCtD
Pentosan Polysulfate—Dizziness—Methotrexate—lymphatic system cancer	0.000638	0.000844	CcSEcCtD
Pentosan Polysulfate—Vomiting—Methotrexate—lymphatic system cancer	0.000614	0.000812	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—lymphatic system cancer	0.000609	0.000805	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—lymphatic system cancer	0.000608	0.000804	CcSEcCtD
Pentosan Polysulfate—Headache—Methotrexate—lymphatic system cancer	0.000605	0.0008	CcSEcCtD
Pentosan Polysulfate—Nausea—Methotrexate—lymphatic system cancer	0.000573	0.000759	CcSEcCtD
